The Health Protection (Coronavirus, International Travel, Operator Liability and Public Health Information to Travellers) (Wales) (Miscellaneous Amendments) (No. 3) Regulations 2021

Amendments to regulation 2A

4.—(1) Regulation 2A (exemptions for vaccinated travellers and others) is amended as follows.

(2) In paragraph (3)(c)—

(a) after paragraph (ii) omit “or”;

(b) after paragraph (iii) insert—

“or

(iv) a vaccine certificate,”.

(3) In paragraph (7), for “paragraphs (3) and (6)” substitute “paragraph (3)”.

(4) After paragraph (7) insert—

“(7A) For the purposes of paragraph (3), where P has received a dose of one authorised vaccine and a dose of a different authorised vaccine, P is deemed to have completed a course of doses of an authorised vaccine.

(7B) For the purposes of paragraph (6), P has completed a course of doses of a vaccine if P has received the complete course of doses of the vaccine as specified in the manufacturer’s guidance for that vaccine.”

(5) In paragraph (8), for “received”, in the second place it occurs, substitute “completed”.

(6) After paragraph (8) insert—

“(8A) For the purposes of paragraph (6), where P has received a dose of one vaccine under the United Kingdom vaccine roll-out overseas, and a dose of a different vaccine under the United Kingdom vaccine roll-out overseas, P is deemed to have completed a course of doses of a vaccine under the United Kingdom vaccine roll-out overseas.”

(7) In paragraph (10)—

(a) for the definition of “authorised vaccine” substitute—

““authorised vaccine” (“brechlyn awdurdodedig”) means a medicinal product for vaccination against coronavirus authorised—

(a)

in relation to doses received in the United Kingdom—

(i)

for supply in the United Kingdom in accordance with a marketing authorisation, or

(ii)

by the licensing authority on a temporary basis under regulation 174 of the Human Medicines Regulations 2012(1);

(b)

in relation to doses received in a relevant country listed in the first column of the table in paragraph (11), for supply in that country following evaluation by the relevant regulator for the country;

(c)

in relation to doses received in a relevant country listed in paragraph (12), in accordance with paragraph (a);”;

(b) for the definition of “marketing authorisation” substitute—

““marketing authorisation” (“awdurdodiad marchnata”)—

(a)

in relation to a vaccine authorised for supply in the United Kingdom or in a member State, has the meaning given in regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012;

(b)

in relation to a vaccine authorised for supply in a relevant country listed in the first column of the table in paragraph (11) other than a member State, means a marketing authorisation granted by the relevant regulator for the country;”;

(c) for the definition of “relevant country” substitute—

““relevant country” (“gwlad berthnasol”) means a country or territory listed in the first column of the table in paragraph (11) or a country or territory listed in paragraph (12);”;

(d) at the appropriate place, insert—

““vaccine certificate” (“tystysgrif brechlyn”) means a certificate in English, French or Spanish issued by the competent health authority of a relevant country which contains—

(a)

P’s full name;

(b)

P’s date of birth;

(c)

the name and manufacturer of the vaccine that P has received;

(d)

the date that P received each dose of the vaccine;

(e)

details of either the identity of the issuer of the certificate or the country of vaccination, or both.”

(8) In the table in paragraph (11), at the appropriate place—

(a) in the first column (relevant country), insert “Australia” and in the second column (relevant regulator) of the same row, insert “The Therapeutic Goods Administration”;

(b) in the first column (relevant country), insert “Canada” and in the second column (relevant regulator), insert “Health Canada”.

(9) After paragraph (11) insert—

“(12) The countries and territories referred to in the definition of “relevant country” are—

• Antigua and Barbuda

• Bahrain

• Barbados

• Brunei

• Dominica

• Israel

• Japan

• Kuwait

• Malaysia

• New Zealand

• Qatar

• Saudi Arabia

• Singapore

• South Korea

• Taiwan

• United Arab Emirates”.

(1)

S.I. 2012/1916.